Latest Debt News

Solstice Minerals has pushed the boundaries of its Nanadie Copper-Gold Project, delivering a massive 722m drill intercept that extends high-grade mineralisation more than 500m below the current resource estimate.

Broken Hill Mines Limited posted a $48.8 million loss for FY2026, driven by acquisition-related costs and re-compliance expenses, despite a 56% revenue increase reflecting production growth at Rasp and Pinnacles mines.

Ashley Services Group delivered a standout FY26 with revenue up 16.7% to $602.2 million and net profit after tax surging 189.5% to $6.29 million, supported by margin gains across key sectors and a strategic acquisition.

PEXA Group delivered a solid FY26 with 7% revenue growth and a return to profitability, while facing a regulatory pricing review that could reshape its future investment capacity.

SomnoMed reported a 3% revenue rise to $114.5 million and a 19% EBITDA increase to $10.9 million in FY26, navigating European market headwinds and a CEO transition while launching its Virtus device targeting sleep apnea with bruxism.

Westgold Resources delivered a landmark FY26 with record gold output, soaring profits, and a strong balance sheet underpinning a 10 cents per share fully franked dividend.

ECS Botanics boosted revenue by 10% to $21.4 million in FY26, delivering positive EBITDA and operating cash flow while advancing international market entry and branded product growth.

Austral Gold nearly doubled its gold equivalent production in the first half of 2026, driven by the Casposo restart and Guanaco operations, delivering a US$15.5 million net profit and extending Guanaco’s mine life to 14 years.

Bisalloy Steel’s FY26 profit fell 16% as softer domestic demand and Indonesian import restrictions weighed, but the company secured a pioneering US submarine steel order and advanced its digital wear-monitoring technology.

Saluda Medical delivered FY26 revenue of US$90.2 million, beating guidance with strong US and international growth, while reporting a flat net loss of US$149.6 million amid ongoing heavy investment. The company’s FDA approval of its CAP24 paddle lead opens a new US surgical market segment.

Mach7 Technologies reported a 17.4% revenue drop to $27.9 million and a 44% increase in net loss to $8.9 million for FY26, driven by a strategic transition to a subscription model and cost base restructuring.

Virgin Australia Holdings (ASX:VGN) posted a 13.4% rise in underlying EBIT to $753 million for FY26, declaring a fully franked dividend of 7.6 cents per share, its first since relisting. The airline’s transformation program, fleet renewal, and operational resilience underpin its improved financial and customer metrics.